• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Canada
  • United Kingdom
  • Subscribe
  • facebook
  • instagram
  • RSS
  • RSMUS.com

The Real Economy Blog

Search

  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences

biotech

5 things to know in life sciences: Week of Feb. 15

Feb. 19, 2021 by Steve Kemler, Adam Lohr and David Stuart

In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug for the treatment of obesity, a new and less invasive treatment for sleep apnea, and a new technology in cardiac catheters. We also examine the impact of the pandemic on oncology trials and the challenges of developing new treatments for Alzheimer’s ... READ MORE >

5 things to know in life sciences: Week of Feb. 8

Feb. 11, 2021 by Steve Kemler, Adam Lohr and David Stuart

In this week’s roundup, we look at the impact of new COVID-19 variants on existing vaccines for the disease; South Africa made the difficult decision to stop using its most readily available vaccine after it showed limited effectiveness against the variant most common there. This is an important reminder that getting the first vaccines approved was a ... READ MORE >

CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements

Feb. 9, 2021 by Adam Lohr

About 100 million people tuned in to the watch the Super Bowl on Sunday – that’s almost four times the number of Americans who have received their first jab of a COVID-19 vaccine. While the world’s largest vaccination effort is not going 100% according to plan, the Centers for Disease Control and Prevention’s vaccination tracker shows that of the 59.3 ... READ MORE >

5 things to know this week in life sciences: Week of Jan. 11

Jan. 15, 2021 by Steve Kemler and Adam Lohr

In this week’s roundup, we take a look at life sciences fundraising totals from 2020, which was a record year for the industry in the capital markets. Silicon Valley Bank provides a detailed look at the numbers and provides insights into what to expect this year. Other news this week included Bluebird Bio’s announcement about splitting into two companies, ... READ MORE >

5 things to know this week in life sciences: Week of Jan. 4

Jan. 7, 2021 by Steve Kemler and Adam Lohr

Each year, pharma companies make updates to their price lists in January. This reliably generates headlines and, occasionally, congressional hearings. In this week’s industry roundup, we take a look at the recent price increases and how they compare to last year’s. We also look at the ongoing battle over 340B program discounts between pharma companies and ... READ MORE >

5 things to know this week in life sciences: Week of Dec. 21

Dec. 23, 2020 by Steve Kemler and Adam Lohr

With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated with the hope that it will help us return to a more normal life. While looking forward, this is also a good time to reflect on the decades of work that laid the groundwork for this lightning fast vaccine development effort, as the ... READ MORE >

Biotech needs cash in hesitant market

Apr. 3, 2019 by Matt Wolf

biotech stock volatility chart

Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. The analysis suggests that over 100 biotech companies, including makers of oncology therapies and treatments for other life-threatening conditions, need to raise ... READ MORE >

Primary Sidebar

Other Regions

  • Canada
  • United Kingdom

Categories

  • Economics
  • Technology
  • Consumer Products
  • Industrials
  • Financial Services
  • Real Estate
  • Health Care
  • Life Sciences

RSMUS.com links

The Real Economy

Middle Market Business Index

MMBI Special Reports

Footer

  • Facebook
  • Instagram
  • RSS

About The Real Economy Blog

The Real Economy Blog from RSM US LLP was developed to provide timely economic insights about the middle market economy. It is offered as a complement to RSM’s macroeconomic thought leadership, including The Real Economy monthly publication and the proprietary RSM US Middle Market Business Index (MMBI).

© 2021 RSMUS.com | Privacy Policy | Cookie Policy

The Real Economy Blog
  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences